The MMR system can be compromised by epigenetic changes, usually by acquired MLH1 promoter hypermethylation, or by genetic inactivation of MLH1, MSH2, MSH6, or PMS2 genes characteristic of Lynch syndrome (LS) [1,2]. Here, MLH1 is linked to Leigh syndrome.